Chamber of Commerce argues Inflation Reduction Act-created program violates U.S. Constitution Case is only one nationally seeking a preliminary injunction Sept 15 (Reuters) - A lawyer for the U.S ...
WASHINGTON — Attorneys for the U.S. Chamber of Commerce and the federal government sparred Friday over whether drugmakers have enough say in Medicare’s new drug price negotiation program, in ...
The Chamber of Commerce urged a federal judge on Friday to stop the new Medicare drug price negotiation program before Oct. 1 ...
The manufacturers of the 10 initial drugs chosen for Medicare’s price negotiation program have agreed to participate in the historic initiative, the Biden administration said Tuesday.
All of the companies had drugs that made the list of the first 10 medications to be subject to Medicare price negotiations. PhRMA, a leading drug industry trade group, and the US Chamber of ...
Drug makers are negotiating with Medicare over lowering the prices of 10 commonly used medications for conditions including ...
Despite at least nine lawsuits against the government, all companies whose drugs are up for Medicare price negotiation will ...
The Biden administration will face the first major legal test of its new Medicare drug pricing authority on Friday, when a federal judge in Ohio hears oral arguments in the first of a wave of ...
The U.S. government's Medicare health insurance program can begin negotiating prices for some prescription drugs this fall under a new program, a federal judge ruled on Friday, vindicating one of ...
A ll of the primary manufacturers of the 10 drugs selected in August for Medicare price negotiations have signed on to participate in the program, the White House said Tuesday.
Sept 15 (Reuters) - A lawyer for the U.S. Chamber of Commerce on Friday urged a federal judge to block President Joe Biden's administration from implementing a new program that would let Medicare ...
Japanese drugmaker Astellas (OTCPK:ALPMF) has withdrawn a federal lawsuit that challenged the US government’s right to negotiate drug prices for its Medicare program, but maintained the newly ...
